Cardiovascular imaging modalities, including echocardiography and cardiac magnetic resonance, are essential for diagnosing stress cardiomyopathy, assessing disease severity, and identifying complications.
Cardiovascular imaging plays a crucial role in the comprehensive management of stress cardiomyopathy, from diagnosis to prognosis.
Stress cardiomyopathy (Takotsubo syndrome) is a reversible syndrome stemming from myocardial injury leading to systolic dysfunction and is usually noted in the setting of a stressful event, be it an emotional or physical trigger. While the exact pathophysiology behind stress cardiomyopathy is yet unknown, there is ample evidence suggesting that neurocardiogenic mechanisms may play an important role. Although historically stress cardiomyopathy was generally thought to be a relatively benign condition, there is growing recognition of the cardiovascular complications associated with it despite its reversibility. Our review aims to shed light onto key cardiovascular imaging modalities used to diagnose stress cardiomyopathy while highlighting the role that imaging plays in assessing disease severity, identifying complications, dictating treatment approaches, and in short-term and long-term prognosis.
Zghyer et al. (Fri,) conducted a review in Stress Cardiomyopathy (Takotsubo Syndrome). Cardiovascular imaging was evaluated. Cardiovascular imaging modalities, including echocardiography and cardiac magnetic resonance, are essential for diagnosing stress cardiomyopathy, assessing disease severity, and identifying complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: